These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Thymidine as a kinetic and biochemical modulator of 1-beta-D-arabinofuranosylcytosine in human acute nonlymphocytic leukemia. Blumenreich MS; Chou TC; Andreeff M; Vale K; Clarkson BD; Young CW Cancer Res; 1984 Feb; 44(2):825-30. PubMed ID: 6692380 [TBL] [Abstract][Full Text] [Related]
50. Combination chemotherapy with risk factor-adjusted dose attenuation for high-risk myelodysplastic syndrome and resulting leukemia in the multicenter study of the Japan Adult Leukemia Study Group (JALSG): results of an interim analysis. Okamoto T; Kanamaru A; Shimazaki C; Motoji T; Takemoto Y; Takahashi M; Fukushima T; Takeshita A; Kusumoto GS; Kishimoto Y; Yorimitsu S; Tsukuda K; Uike N; Arima N; Ohno R Int J Hematol; 2000 Aug; 72(2):200-5. PubMed ID: 11039669 [TBL] [Abstract][Full Text] [Related]
51. Maintenance management of acute nonlymphocytic leukemia. Lewis JP; Pajak TF; Linman JW; Bateman JR Cancer Clin Trials; 1981; 4(2):115-24. PubMed ID: 7249249 [TBL] [Abstract][Full Text] [Related]
52. [Combination chemotherapy using adriamycin as a principal drug and supportive therapy of adult T-cell leukemia]. Taguchi H; Niiya K; Kubonishi I; Miyoshi I; Shiomi F; Machida K; Ueda N Rinsho Ketsueki; 1982 Aug; 23(8):1183-91. PubMed ID: 6982983 [No Abstract] [Full Text] [Related]
53. [Combination chemotherapy using 5-fluorouracil, chromomycin A3 and prednisolone for solid tumors (author's transl)]. Saito T; Wakui A; Yokoyama M; Himori T; Takahashi H Nihon Gan Chiryo Gakkai Shi; 1973 Dec; 8(4):336-51. PubMed ID: 4798945 [No Abstract] [Full Text] [Related]
55. [Patient with hypoplastic leukemia successfully treated with N4-palmitoyl-1-beta-D-arabinofuranosyl cytosine]. Uchida M; Tsutani H; Kagawa D; Ueda T; Domae N; Nakamura T Nihon Naika Gakkai Zasshi; 1985 Dec; 74(12):1709-13. PubMed ID: 3831195 [No Abstract] [Full Text] [Related]
56. [Intermittent drip infusion of antibiotic combinations in massive dosages and associated nursing care - in case of acute leukemia]. Ishihara M; Matsumoto Y Kango Gijutsu; 1978 May; 24(7):49-57. PubMed ID: 248483 [No Abstract] [Full Text] [Related]
57. Mechanism of the cardiovascular actions of cyclocytidine. Burks TF; Loo TL; Grubb MN Proc Soc Exp Biol Med; 1978 Dec; 159(3):374-9. PubMed ID: 83653 [No Abstract] [Full Text] [Related]
58. [Consolidation and intensification of complete remission in acute leukemia (author's transl)]. Uetani T; Sako F; Imamura K; Hirano M; Imai K Rinsho Ketsueki; 1973 Nov; 14(11):1086-94. PubMed ID: 4798807 [No Abstract] [Full Text] [Related]
59. Pharmacokinetic prodrug modeling: in vitro and in vivo kinetics and mechanisms of ancitabine bioconversion to cytarabine. Kirsch LE; Notari RE J Pharm Sci; 1984 Jun; 73(6):728-32. PubMed ID: 6204036 [TBL] [Abstract][Full Text] [Related]
60. [Clinical analysis of 20 cases of lymphosarcoma cell leukemia (author's transl)]. Wang ZY Zhonghua Nei Ke Za Zhi; 1980 Mar; 19(2):126-7. PubMed ID: 7472041 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]